石四药集团(02005)10月6日斥资869.89万港元回购300万股

Core Viewpoint - The company, Stone Four Pharmaceutical Group, announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will spend HKD 8.6989 million to repurchase 3 million shares [1]